Mochida Pharmaceutical Co., Ltd. (4534) Stock Statistics & Valuation Metrics

Mochida Pharmaceutical Co., Ltd. has a market cap or net worth of JPY 111.44B. The enterprise value is JPY 95.36B.

Market Cap

JPY 111.44B

Enterprise Value

JPY 95.36B

Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

36,390,000

Owned by Insiders

―

Owned by Institutions

6.13%

Mochida Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.63%.

Return on Equity (ROE)

0.06

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

4.63%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

79.07M

Profits Per Employee

5.34M

Employee Count

1,479

Asset Turnover

0.64

Inventory Turnover

1.68

The current PE Ratio of Mochida Pharmaceutical Co., Ltd. is 12.54. Mochida Pharmaceutical Co., Ltd.’s PEG ratio is 0.24.

PE Ratio

12.54

PS Ratio

0.94

PB Ratio

0.82

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

0.24

In the last 12 months, Mochida Pharmaceutical Co., Ltd. had revenue of 116.95B and earned 7.90B in profits. Earnings per share was 222.93.

Revenue

116.95B

Gross Profit

56.26B

Operating Income

10.15B

Pretax Income

11.17B

Net Income

7.90B

EBITDA

13.13B

Earnings Per Share (EPS)

222.93

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

Mochida Pharmaceutical Co., Ltd. pays an annual dividend of JPY 40.00, resulting in a dividend yield of 2.43%

Dividend Per Share

JPY 40.00

Dividend Yield

2.43%

Payout Ratio

42.23%

Free Cash Flow Yield

0.00%

Earnings Yield

7.64%

Beta

0.62

52-Week Price Change

11.86%

50-Day Moving Average

3208.41

200-Day Moving Average

3322.52

Relative Strength Index (RSI)

57.08

Average Volume (3m)

44.42K

Mochida Pharmaceutical Co., Ltd. upcoming earnings date is Nov 09, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 03, 2026

Next Earnings Date

Nov 09, 2026

Ex-Dividend Date

Mar 30, 2026

Mochida Pharmaceutical Co., Ltd. as a current ratio of 4.29, with Debt / Equity ratio of 7.13%

Current Ratio

4.29

Quick Ratio

2.99

Debt to Market Cap

0.08

Net Debt to EBITDA

-1.38

Interest Coverage Ratio

140.94

In the past 12 months, Mochida Pharmaceutical Co., Ltd. has paid 3.27B in taxes.

Income Tax

3.27B

Effective Tax Rate

0.29

Mochida Pharmaceutical Co., Ltd. EV to EBITDA ratio is 7.24, with an EV/FCF ratio of 0.00.

EV to Sales

0.84

EV to EBITDA

7.24

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

Mochida Pharmaceutical Co., Ltd. has JPY 28.41B in cash and marketable securities with JPY 10.81B in debt, giving a net cash position of JPY 17.60B billion.

Cash & Marketable Securities

JPY 28.41B

Total Debt

JPY 10.81B

Net Cash

JPY 17.60B

Net Cash Per Share

JPY 483.54

Tangible Book Value Per Share

JPY 3,932.67

Gross margin is 46.97%, with operating margin of 9.13%, and net profit margin of 7.53%.

Gross Margin

46.97%

Operating Margin

9.13%

Pretax Margin

10.86%

Net Profit Margin

7.53%

EBITDA Margin

11.60%

EBIT Margin

9.13%

The average price target for Mochida Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

14.72%

EPS Growth Forecast

52.55%

Smart Score

―

AI Score

68